Podcast appearances and mentions of Dan Larkin

Dr. Dan Larkin from the Department of Fisheries, Wildlife, and Conservation Biology at the U of M discusses invasive aquatic species, issues with current control methods, and how we can better work to improve treatment of them while protecting native plants. 

Newest BOOMer and all-around stud, Dan Larkin joins the pod. Join us for an epic edition of “Ask Lloyd Anything”, see how many times we mention Ja'Marr Chase, and forget the Super Bowl predictions - who's coming in LAST? Tonight on Entering Milford. Watch on YouTube: https://youtu.be/Y4pteR6W_TI --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/enteringmilford/support

A panel discussion at the Brewery, with Q&A, on the topic: The Challenge of Biblical Interpretation. Featuring Dr. Dan Larkin, Dr. Dan Piaski, and myself. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit statesboro.substack.com

Episode 32: Dan Larkin CEO & Founder of Go Solo by Grow to Gold

A panel discussion at the Brewery, with Q&A, on the topic: What is God? Featuring Dr. Dan Piaski, Dr. Dan Larkin, and myself. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit statesboro.substack.com

A panel discussion at the Brewery, with Q&A, on the topic: Hell. Featuring Dr. Dan Piaski, myself, Dr. Allison Prude, and Dr. Dan Larkin. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit statesboro.substack.com

Nate has an inspiring conversation with his brother, Dan.  After a series of strokes, Dan was left unable to speak and was told by doctors that he would never speak again.  But Dan didn't accept that prognosis.  Through hard work and sheer determination, he discovered his own path for healing, proving the incredible resilience of the human brain.  The parallels with the recovery journey are evident.  Also, with our 300th episode right around the corner, the guys are requesting submission of questions, comments, memories and reflections of how the podcast has impacted you. Send to piratemonkpodcast@gmail.com and the fellas will share them on the show.   The music on this podcast is contributed by members of the Samson Society. For more information on this ministry, please visit samsonsociety.com.

This week's contestant is Contestant is Dan Larkin from Windsor, California.

This week's contestant is Contestant is Dan Larkin from Windsor, California.

I thoroughly enjoyed having Ruth Fisher, Ph.D., Cannabis researcher, and analyst, Co-Founder of Cann Dynamics, as well as the author of The Medical Cannabis Primer, on TSC Talks! I heard about Ruth’s book from another recent guest, Nikki Lawley and promptly ordered it, and reached out to Ruth for an interview. It’s a phenomenal resource, one that I have on my desk and refer to frequently. Before I launch into the episode notes, here’s a great description of the book written by Dan Larkin, that I found helpful: “Getting clear, concise, and easy to understand information about cannabis is tough. There are lots of resources, but which ones can you trust? How can you be sure the information isn’t biased? How are you supposed to even understand all the terminology and science? Is it even legal?All of this becomes doubly important if you’re researching medical cannabis as an alternative to conventional treatments or pharmaceuticals. You or someone you love may have recently been diagnosed with cancer, epilepsy, autism, MS, or PTSD. You may have been dealing with chronic pain. Whatever your personal reason, you deserve access to clear, concise information about medical cannabis….That’s where “The Medical Cannabis Primer” by Ruth D. Fisher, Ph.D. and edited & designed by her brother, A. Arthur Fisher, comes in. They’ve assembled a comprehensive, easy to read compendium of cannabis knowledge that’s full of unbiased information and easy to understand charts, graphs, and images.”Ruth shares that it was through the process of helping her brother, who was diagnosed with Multiple Sclerosis, find adequate treatment, that she ended up researching cannabis. Raised by a father who was a private practice physician, a successful children's eye doctor, and Ruth’s idol, she speaks of his influence, “My dad was also an iconoclast, he didn't take things at face value, just because people said so. He did research in his area of medicine, and he questioned authority. And he encouraged us to do so. He would send us stuff to read a lot. And he would send an article and say, “read this article.!”, I'm like, “Dad, just tell me what it says.” He says, “No, I want you to read it yourself”. And that was always a pain. But at some point, I realized he didn't want to bias, the presentation of the information his view and his perspective. He wanted us to read it for ourselves and develop our own perspective or interpretation on what we thought of it. I always thought that was very interesting. It took me a long time to appreciate that”Another formative factor Ruth mentions as shaping her life view was graduate school. “ I'm an economist. In economics, you learn that everything is supply and demand. So, you learn how you know all markets are shaped by the forces of supply and demand and you kind of understand things in those terms…. What's really interesting, and it was finally drummed into me that it doesn't matter what the results are. If your data and methodology aren't valid, they're not found, then the results don't matter. They're meaningless. That was really, really important in forming my attitudes about reading research and trying to evaluate whether or not I should consider them to be valid, based on the methodology and the data used. And it really, really impressed upon me the importance of good methodology in order to provide valid results.”Here are a few quotes from the transcript of our interview highlighting Ruth’s entry into the cannabis industry and her realization that educating herself was necessary, “So I got into cannabis about four or five years ago. My brother started having health problems. And it turns out he was eventually diagnosed with multiple sclerosis. And MS manifests itself differently in different people and the manifestation he gets is pain, a lot of neuropathic pain from different sources. And he was on a lot of different drugs trying to control or manage the pain and they all have really, really ugly side effects. And while they were helping some they weren't really doing enough. And my brother’s neurologist said, you know, maybe you could use benefit from cannabis""So, I will say that, yes, I had also smoked cannabis or pot in college and decided to, you know, wasn't my thing. And I knew that it was out there in the medical world, but really didn't pay any attention to it. I come in now, and the situation is, my brother has a lot of pain. He has chronic pain. And all I know is I want to do anything I can to help him minimize his pain. And so, I go into cannabis and my job as I saw it was to go in and figure out if cannabis was for real, and if so help him figure out what would help him. And so my goal here was to cut through all the BS and I didn't care what anyone had to say whether they were pro or anti, all I cared about was finding something that would help reduce my brother's pain. So, I drew upon all my past experiences in approaching things and I started reading…th first question was, well, what is cannabis and how does it work on the body? And I started reading about that and wow, kind of overwhelming.”Ruth explains the challenges to finding well-rounded information and unbiased research on cannabis for multiple reasons and goes into detail on why this is so. Here’s one quote elaborating on this issue.“In 1937 with the Marijuana Tax Act, the funds for research essentially dried up, not fully -there was a trickle of funding, but they largely dried up, except for NIDA. And so, you had this, and then in 1970, with the Controlled Substances Act when cannabis was officially categorized as a schedule one drug, all of a sudden, there's this one department within the National Institute of Health that had all this money to study the bad effects of cannabis. If you want to study the good effects, then it's really hard to get funding and it's really onerous. There's a lot of restrictions, you have to file with the DEA and get permission from them. You have to go through all these hoops with the government. It's really difficult and it's really stigmatized. You know, it could hurt your career if you do this”She summarizes the state of research, “when people in the healthcare industry say there's no evidence that cannabis has been shown to be safe and effective, what they mean is no studies period, they mean no large scale clinical trials. And a large scale clinical trial is very expensive. And it's generally done by someone who's seeking FDA approval for a pharmaceutical. There are certain cannabis pharmaceuticals out there. And they've gone through a number of clinical trials. But again, those are isolates. And people who are doing the whole plant medicine and who are finding really amazing results. They don't have the money to fund large scale clinical trials. And I'm not trying, I'm not trying to make an excuse. I'm trying to explain why that evidence doesn't exist.”This episode is rich with information and I personally learned a ton through the process of preparing for and interviewing Ruth and then reading her book. I’ll leave you with a final quote but please take the time to listen to this thorough, fascinating and very personal discussion providing not only information on medical cannabis such as dosing, forms of use, whole plant, but the many factors that have influenced healthcare opposition, recent advances, risks and more.“The big problem I had is the people who are close to it, and who have patients who are afraid to tell them that they're using cannabis because now you're missing all the interactions. And now you're going to have people using it with zero oversight from their doctors, and you're going to cause all sorts of problems. So, I think the first step is for the doctors to start learning from the patients and just being open to it. I know that my brother had a neurologist, and very early on, he had some really, really bad symptoms. And very early on, he was going through things and he got to the point many times where he's like, I am willing to try anything to address this problem. And at one point, you know, he got to diet, and he put himself on a very limited diet. And lo and behold, that solved a lot of his problem. And he went to one of his neurologists, his neurologist who's making different recommendations. And my brother said, Well, you know, I changed my diet, and that has really helped. And the neurologist said, Yeah, you know, I've heard that from other patients, but I really know nothing about nutrition, so I can't really comment on that. And Eddie, that doctor did end up becoming informed on nutrition and actually now incorporates that into his programs.” Here are Ruth’s links:Order: https://www.amazon.com/Medical-Cannabis-Primer-Ushering-Marijuana/dp/1885176023https://www.linkedin.com/in/rfisher/https://medicalcannabisprimer.com/ https://www.quantaa.com/ https://canndynamics.com/ https://incolor.net/news https://www.cedfoundation.com/2019/06/07/ruth-fishers-cannabis-primer-book/ https://www.techzone360.com/topics/techzone/articles/2020/01/30/444355-canndynamics-co-founder-educate-engage-cannabis-the-blockchain.htm https://www.independent.com/2020/01/06/the-medical-cannabis-primer-cuts-through-the-crap/

I thoroughly enjoyed having Ruth Fisher, Ph.D., Cannabis researcher, and analyst, Co-Founder of Cann Dynamics, as well as the author of The Medical Cannabis Primer, on TSC Talks! I heard about Ruth’s book from another recent guest, Nikki Lawley and promptly ordered it, and reached out to Ruth for an interview. It’s a phenomenal resource, one that I have on my desk and refer to frequently. Before I launch into the episode notes, here’s a great description of the book written by Dan Larkin, that I found helpful: “Getting clear, concise, and easy to understand information about cannabis is tough. There are lots of resources, but which ones can you trust? How can you be sure the information isn’t biased? How are you supposed to even understand all the terminology and science? Is it even legal? All of this becomes doubly important if you’re researching medical cannabis as an alternative to conventional treatments or pharmaceuticals. You or someone you love may have recently been diagnosed with cancer, epilepsy, autism, MS, or PTSD. You may have been dealing with chronic pain. Whatever your personal reason, you deserve access to clear, concise information about medical cannabis….That’s where “The Medical Cannabis Primer” by Ruth D. Fisher, Ph.D. and edited & designed by her brother, A. Arthur Fisher, comes in. They’ve assembled a comprehensive, easy to read compendium of cannabis knowledge that’s full of unbiased information and easy to understand charts, graphs, and images.” Ruth shares that it was through the process of helping her brother, who was diagnosed with Multiple Sclerosis, find adequate treatment, that she ended up researching cannabis. Raised by a father who was a private practice physician, a successful children's eye doctor, and Ruth’s idol, she speaks of his influence, “My dad was also an iconoclast, he didn't take things at face value, just because people said so. He did research in his area of medicine, and he questioned authority. And he encouraged us to do so. He would send us stuff to read a lot. And he would send an article and say, “read this article.!”, I'm like, “Dad, just tell me what it says.” He says, “No, I want you to read it yourself”. And that was always a pain. But at some point, I realized he didn't want to bias, the presentation of the information his view and his perspective. He wanted us to read it for ourselves and develop our own perspective or interpretation on what we thought of it. I always thought that was very interesting. It took me a long time to appreciate that” Another formative factor Ruth mentions as shaping her life view was graduate school. “ I'm an economist. In economics, you learn that everything is supply and demand. So, you learn how you know all markets are shaped by the forces of supply and demand and you kind of understand things in those terms…. What's really interesting, and it was finally drummed into me that it doesn't matter what the results are. If your data and methodology aren't valid, they're not found, then the results don't matter. They're meaningless. That was really, really important in forming my attitudes about reading research and trying to evaluate whether or not I should consider them to be valid, based on the methodology and the data used. And it really, really impressed upon me the importance of good methodology in order to provide valid results.” Here are a few quotes from the transcript of our interview highlighting Ruth’s entry into the cannabis industry and her realization that educating herself was necessary, “So I got into cannabis about four or five years ago. My brother started having health problems. And it turns out he was eventually diagnosed with multiple sclerosis. And MS manifests itself differently in different people and the manifestation he gets is pain, a lot of neuropathic pain from different sources. And he was on a lot of different drugs trying to control or manage the pain and they all have really, really ugly side effects. And while they were helping some they weren't really doing enough. And my brother’s neurologist said, you know, maybe you could use benefit from cannabis" "So, I will say that, yes, I had also smoked cannabis or pot in college and decided to, you know, wasn't my thing. And I knew that it was out there in the medical world, but really didn't pay any attention to it. I come in now, and the situation is, my brother has a lot of pain. He has chronic pain. And all I know is I want to do anything I can to help him minimize his pain. And so, I go into cannabis and my job as I saw it was to go in and figure out if cannabis was for real, and if so help him figure out what would help him. And so my goal here was to cut through all the BS and I didn't care what anyone had to say whether they were pro or anti, all I cared about was finding something that would help reduce my brother's pain. So, I drew upon all my past experiences in approaching things and I started reading…th first question was, well, what is cannabis and how does it work on the body? And I started reading about that and wow, kind of overwhelming.” Ruth explains the challenges to finding well-rounded information and unbiased research on cannabis for multiple reasons and goes into detail on why this is so. Here’s one quote elaborating on this issue. “In 1937 with the Marijuana Tax Act, the funds for research essentially dried up, not fully -there was a trickle of funding, but they largely dried up, except for NIDA. And so, you had this, and then in 1970, with the Controlled Substances Act when cannabis was officially categorized as a schedule one drug, all of a sudden, there's this one department within the National Institute of Health that had all this money to study the bad effects of cannabis. If you want to study the good effects, then it's really hard to get funding and it's really onerous. There's a lot of restrictions, you have to file with the DEA and get permission from them. You have to go through all these hoops with the government. It's really difficult and it's really stigmatized. You know, it could hurt your career if you do this” She summarizes the state of research, “when people in the healthcare industry say there's no evidence that cannabis has been shown to be safe and effective, what they mean is no studies period, they mean no large scale clinical trials. And a large scale clinical trial is very expensive. And it's generally done by someone who's seeking FDA approval for a pharmaceutical. There are certain cannabis pharmaceuticals out there. And they've gone through a number of clinical trials. But again, those are isolates. And people who are doing the whole plant medicine and who are finding really amazing results. They don't have the money to fund large scale clinical trials. And I'm not trying, I'm not trying to make an excuse. I'm trying to explain why that evidence doesn't exist.” This episode is rich with information and I personally learned a ton through the process of preparing for and interviewing Ruth and then reading her book. I’ll leave you with a final quote but please take the time to listen to this thorough, fascinating and very personal discussion providing not only information on medical cannabis such as dosing, forms of use, whole plant, but the many factors that have influenced healthcare opposition, recent advances, risks and more. “The big problem I had is the people who are close to it, and who have patients who are afraid to tell them that they're using cannabis because now you're missing all the interactions. And now you're going to have people using it with zero oversight from their doctors, and you're going to cause all sorts of problems. So, I think the first step is for the doctors to start learning from the patients and just being open to it. I know that my brother had a neurologist, and very early on, he had some really, really bad symptoms. And very early on, he was going through things and he got to the point many times where he's like, I am willing to try anything to address this problem. And at one point, you know, he got to diet, and he put himself on a very limited diet. And lo and behold, that solved a lot of his problem. And he went to one of his neurologists, his neurologist who's making different recommendations. And my brother said, Well, you know, I changed my diet, and that has really helped. And the neurologist said, Yeah, you know, I've heard that from other patients, but I really know nothing about nutrition, so I can't really comment on that. And Eddie, that doctor did end up becoming informed on nutrition and actually now incorporates that into his programs.” Here are Ruth’s links: Order: https://www.amazon.com/Medical-Cannabis-Primer-Ushering-Marijuana/dp/1885176023 https://www.linkedin.com/in/rfisher/ https://medicalcannabisprimer.com/ https://www.quantaa.com/ https://canndynamics.com/ https://incolor.net/news https://www.cedfoundation.com/2019/06/07/ruth-fishers-cannabis-primer-book/ https://www.techzone360.com/topics/techzone/articles/2020/01/30/444355-canndynamics-co-founder-educate-engage-cannabis-the-blockchain.htm https://www.independent.com/2020/01/06/the-medical-cannabis-primer-cuts-through-the-crap/

A panel discussion on death and the afterlife from Eagle Creek Brewery on February 18, 2020. Dr. Dan Piaski, Rev. Drew Miller, and Dr. Dan Larkin. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit statesboro.substack.com

KBEM's new station manager, Dan Larkin, stopped by the Morning Show to talk about his new role at Jazz88.

KBEM's new station manager, Dan Larkin, stopped by the Morning Show to talk about his new role at Jazz88.

KBEM's new station manager, Dan Larkin, stopped by the Morning Show to talk about his new role at Jazz88.

Take a minute to get caught up on everything that's happening at CannabisIRL.com- Cannabis In Real Life

Take a minute to hear what's happening this week at CannabisIRL.com

Take a minute to catch up on what's happening at CannabisIRL.com

Take a minute to catch-up on what's happening at CannabisIRL.com

Take one minute to find out what's happening at CannabisIRL.com

Catch up on what's happening at CannabisIRL.com with Dan Larkin's 1-minute podcast.

Take 60 seconds to catch-up on what's happening this week at CannabisIRL.com.

Dan Larkin talks to Fionna Sebastiano about the role cannabis has played in giving her back her life. Recorded outside on a summer day, Fionna was happy to share her Cannabis In Real Life story in hopes that it inspires others to get past the stigma in order to experience all the plant has to offer.

Take a minute to catch up on what's happening at CannabisIRL.com

Take a minute to catch up on some of the stories you'll find at CannabisIRL.com

Cannabis In Real Life Podcast with Dan Larkin. Take a minute to hear what's happening at CannabisIRL.com

Cannabis In Real Life with Dan Larkin is a one minute snapshot of what's happening at CannabisIRL.com. Real People. Real Stories. Real Life.

Cannabis In Real Life Podcast with Dan Larkin -024

Cannabis In Real Life Podcast with Dan Larkin- 023 Take a minute to get caught up on what you missed this week at CannabisIRL.com

Cannabis In Real Life Podcast with Dan Larkin-022

Cannabis In Real Life Podcast with Dan Larkin-021

Cannabis In Real Life with Dan Larkin #020 1-minute podcast

Cannabis In Real Life with Dan Larkin- #018 1-minute podcast

Cannabis In Real Life with Dan Larkin #017 1-minute podcast

Cannabis In Real Life with Dan Larkin #016 (1 minute)

Cannabis In Real Life with Dan Larkin 1-minute podcast

Cannabis In Real Life with Dan Larkin #014

Cannabis In Real Life with Dan Larkin-013

Cannabis In Real Life with Dan Larkin #12

Cannabis In Real Life with Dan Larkin #011

Cannabis In Real Life with Dan Larkin #007

Cannabis In Real Life with Dan Larkin #006

Cannabis In Real Life with Dan Larkin-#005

Cannabis In Real Life with Dan Larkin 2-14-19

This is Cannabis In Real Life with Dan Larkin for 2-13-19 Learn more at: www.cannabisirl.com

The one minute audio version of Cannabis In Real Life with Dan Larkin. Learn more at: www.cannabisirl.com

"As one of the pioneers of partnerships for the FBI, Dan Larkin of the FBI’s Cyber Division will outline how the FBI has taken this concept from rhetoric to reality over the past 5 years. This presentation will explore how the mantra make it "personal" has aided the FBI in forging exceptional alliances with key stake holders from industry, academia and law enforcement both domestically and abroad. This presentation will also outline how such collaborations have helped to proactively advance the fight against an increasingly international and organized, cyber crime threat. Dan Larkin became unit chief of the Internet Crime Complaint Center (IC3), which is a join initiative between the FBI and the National White Collar Crime Center (NW3C) in January 2003. Before that he was a supervisory special agent (SSA) in the White Collar Crime area for ten years. In that capacity he supervised and coordinated numerous joint agency initiatives on both regional and national levels involving corruption and fraud associated with a variety of federal, state, and local agencies. SSA Larkin acted as the congressional investigative team leader in the "Operation Illwind" Pentagon scandal corruption investigation. The combined effort of this team led to record settlements and convictions involving numerous top defense contractors, as well as public officials. Prior to his current assignment UC Larkin developed and supervised the High Tech Crimes Task Force in Western Pennsylvania, one of the first such initiatives in the United States. UC Larkin also developed a national initiative known as the National Cyber Forensics and Training Alliance (NCFTA) This progressive initiative maximizes overlapping public/private sector resources, in identifying and proactively targeting escalating cyber-crime perpetrators both domestically and abroad. This project also serves to attract a perpetual stream of key Subject Matter Experts (SME's) from industry, government and academia, creating a dynamic cyber-nerve-center, for tactical and proactive response, forensics and vulnerability analysis, and the development of advanced training. UC Larkin also co-authored the FBI’s re-organization plan in 2002 which established Cyber Crime as a top priority, and underscored the need for additional Public/Private Alliances in combating priority cyber crimes word-wide."

As one of the pioneers of partnerships for the FBI, Dan Larkin of the FBI’s Cyber Division will outline how the FBI has taken this concept from rhetoric to reality over the past 5 years. This presentation will explore how the mantra "make it personal" has aided the FBI in forging exceptional alliances with key stake holders from industry, academia and law enforcement both domestically and abroad. This presentation will also outline how such collaborations have helped to proactively advance the fight against an increasingly international and organized, cyber crime threat. Dan Larkin became unit chief of the Internet Crime Complaint Center (IC3), which is a join initiative between the FBI and the National White Collar Crime Center (NW3C) in January 2003. Before that he was a supervisory special agent (SSA) in the White Collar Crime area for ten years. In that capacity he supervised and coordinated numerous joint agency initiatives on both regional and national levels involving corruption and fraud associated with a variety of federal, state, and local agencies. SSA Larkin acted as the congressional investigative team leader in the "Operation Illwind" Pentagon scandal corruption investigation. The combined effort of this team led to record settlements and convictions involving numerous top defense contractors, as well as public officials. Prior to his current assignment UC Larkin developed and supervised the High Tech Crimes Task Force in Western Pennsylvania, one of the first such initiatives in the United States. UC Larkin also developed a national initiative known as the National Cyber Forensics and Training Alliance (NCFTA) This progressive initiative maximizes overlapping public/private sector resources, in identifying and proactively targeting escalating cyber-crime perpetrators both domestically and abroad. This project also serves to attract a perpetual stream of key Subject Matter Experts (SME's) from industry, government and academia, creating a dynamic cyber-nerve-center, for tactical and proactive response, forensics and vulnerability analysis, and the development of advanced training. UC Larkin also co-authored the FBI’s re-organization plan in 2002 which established Cyber Crime as a top priority, and underscored the need for additional Public/Private Alliances in combating priority cyber crimes word-wide."